{"id":11227,"date":"2024-07-16T15:35:48","date_gmt":"2024-07-16T12:35:48","guid":{"rendered":"https:\/\/ivmed.agency\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/"},"modified":"2024-07-16T15:45:20","modified_gmt":"2024-07-16T12:45:20","slug":"transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci","status":"publish","type":"post","link":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/","title":{"rendered":"Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Leczenie niep\u0142odno\u015bci mo\u017ce by\u0107 czasami do\u015b\u0107 skomplikowane i czasoch\u0142onne, zw\u0142aszcza gdy ci\u0105\u017ca nie wyst\u0119puje pomimo najlepszych stara\u0144 pacjentki i lekarzy. Przypadki z niskiej jako\u015bci oocytami i zarodkami s\u0105 uwa\u017cane za szczeg\u00f3lnie trudne do przezwyci\u0119\u017cenia. Ponadto ani lekarze, ani pacjenci nie s\u0105 w stanie z wyprzedzeniem zidentyfikowa\u0107 i zapobiec wielu problemom, kt\u00f3re mog\u0105 pojawi\u0107 si\u0119 w trakcie leczenia.<\/p>\n\n<h2 class=\"wp-block-heading\">Czym jest transfer j\u0105drowy?<\/h2>\n\n<p class=\"wp-block-paragraph\">Transfer j\u0105drowy (NT) to nowe podej\u015bcie do leczenia niep\u0142odno\u015bci, kt\u00f3re polega na przeniesieniu materia\u0142u j\u0105drowego pacjentki do cytoplazmy kom\u00f3rki jajowej dawczyni. Logika stoj\u0105ca za t\u0105 metod\u0105 polega na tym, \u017ce niekt\u00f3re negatywne czynniki mog\u0105 by\u0107 zwi\u0105zane z cytoplazm\u0105 oocytu i mog\u0105 zosta\u0107 przezwyci\u0119\u017cone poprzez zast\u0105pienie cytoplazmy.<\/p>\n\n<p class=\"wp-block-paragraph\">Wewn\u0119trzne czynniki embrionalne, kt\u00f3re prowadz\u0105 do zatrzymania embrionalnego:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Cechy ekspresji gen\u00f3w<\/li>\n\n\n\n<li>Zaburzenia ilo\u015bci i funkcji mitochondrialnego DNA<\/li>\n\n\n\n<li>Cechy metylacji<\/li>\n\n\n\n<li>Ma\u0142e niekoduj\u0105ce RNA<\/li>\n\n\n\n<li>Nieprawid\u0142owo\u015bci chromosomalne<\/li>\n\n\n\n<li>Profil metaboliczny zarodka<\/li>\n\n\n\n<li>Specyficzne cechy morfologiczne, w szczeg\u00f3lno\u015bci wakuolizacja<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\">Rola mitochondri\u00f3w w oocytach<\/h2>\n\n<p class=\"wp-block-paragraph\">Oocyty maj\u0105 najwi\u0119ksz\u0105 liczb\u0119 mitochondri\u00f3w i kopii mitochondrialnego DNA (mtDNA) w por\u00f3wnaniu z innymi kom\u00f3rkami w organizmie. Mitochondria w oocytach pe\u0142ni\u0105 dwie g\u0142\u00f3wne role: wspieraj\u0105 potrzeby metaboliczne oocytu i reguluj\u0105 apoptoz\u0119, jednocze\u015bnie s\u0142u\u017c\u0105c jako rezerwuar nienaruszonego mtDNA dla przysz\u0142ego rozwoju potomstwa. Podczas rekrutacji p\u0119cherzyk\u00f3w masa mitochondri\u00f3w mo\u017ce wzrosn\u0105\u0107 z 6000 kopii mtDNA do 200000, co czyni je bardziej podatnymi na mutacje i delecje.<\/p>\n\n<h2 class=\"wp-block-heading\">Metody transferu j\u0105drowego<\/h2>\n\n<p class=\"wp-block-paragraph\">Istnieje kilka metod transferu j\u0105dra, kt\u00f3re s\u0105 stosowane zar\u00f3wno przed, jak i po zap\u0142odnieniu:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Przed zap\u0142odnieniem: Transfer p\u0119cherzyka zarodkowego (GVT), Transfer wrzeciona podzia\u0142u chromosomowego (MIST | MIIST), Transfer pierwszego cia\u0142a polarnego (PB1GT).<\/li>\n\n\n\n<li>Po zap\u0142odnieniu: Transfer drugiego cia\u0142a polarnego (PB2GT), Transfer pronuklearny (PNT)<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\">Do\u015bwiadczenie z klinik\u0105 IVMED<\/h2>\n\n<p class=\"wp-block-paragraph\">W\u015br\u00f3d pacjent\u00f3w, kt\u00f3rzy przeszli transfer wrzeciona rozszczepiaj\u0105cego i cia\u0142 biegunowych (MS i PB1), \u015bredni wiek pacjent\u00f3w wynosi 40,3 roku, a \u015brednia liczba wcze\u015bniejszych pr\u00f3b IVF-ICSI wynosi 3,3. Wykorzystali\u015bmy 99 oocyt\u00f3w M II od pacjent\u00f3w i 166 oocyt\u00f3w M II od dawc\u00f3w. Udana rekonstrukcja zosta\u0142a osi\u0105gni\u0119ta w 86% przypadk\u00f3w, przy wska\u017aniku fragmentacji wynosz\u0105cym 60% i wska\u017aniku tworzenia blastocyst wynosz\u0105cym 29%.<\/p>\n\n<p class=\"wp-block-paragraph\">\u015aredni wiek pacjentek poddanych transferowi przedj\u0105drowemu (PNT) wynosi\u0142 39,7 lat, a \u015brednia liczba wcze\u015bniejszych pr\u00f3b ICSI wynosi\u0142a 3,8. Wykorzystali\u015bmy 185 oocyt\u00f3w M II od pacjent\u00f3w i 277 oocyt\u00f3w M II od dawc\u00f3w. Udana rekonstrukcja zosta\u0142a osi\u0105gni\u0119ta w 83,4% przypadk\u00f3w, odsetek fragmentacji pnia wyni\u00f3s\u0142 72,2%, a odsetek tworzenia blastocyst wyni\u00f3s\u0142 44%.<\/p>\n\n<h2 class=\"wp-block-heading\">Wnioski<\/h2>\n\n<p class=\"wp-block-paragraph\">Rekonstrukcja oocyt\u00f3w w niekt\u00f3rych przypadkach mo\u017ce by\u0107 rozwa\u017cana jako alternatywa dla dawstwa oocyt\u00f3w. Wyb\u00f3r konkretnej techniki zale\u017cy od liczby i jako\u015bci oocyt\u00f3w, a tak\u017ce sytuacji klinicznej. Choroby mitochondrialne nie zawsze s\u0105 wskazaniem do transferu j\u0105drowego, je\u015bli nie istnieje technologia pozwalaj\u0105ca na ca\u0142kowite usuni\u0119cie matczynego mtDNA. NP s\u0105 mniej skuteczne w przypadku starszych kobiet. Ka\u017cdy przypadek jest wyj\u0105tkowy i wymaga indywidualnego podej\u015bcia. Zastosowanie NPs pozwala zaj\u015b\u0107 w ci\u0105\u017c\u0119 w przypadkach, w kt\u00f3rych standardowe zap\u0142odnienie in vitro nie dzia\u0142a.<\/p>\n\n<p class=\"wp-block-paragraph\">Dzi\u015b mamy \u017cywe urodzenia po takim leczeniu, co jest naszym wsp\u00f3lnym osi\u0105gni\u0119ciem z naszymi pacjentami!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Transfer j\u0105drowy (NT) to nowe podej\u015bcie do leczenia niep\u0142odno\u015bci, kt\u00f3re polega na przeniesieniu materia\u0142u j\u0105drowego pacjentki do cytoplazmy kom\u00f3rki jajowej dawczyni.  <\/p>\n","protected":false},"author":9,"featured_media":11210,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[424],"tags":[],"class_list":["post-11227","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-o-nieplodnosci"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci - IVMED Family Agency<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci - IVMED Family Agency\" \/>\n<meta property=\"og:description\" content=\"Transfer j\u0105drowy (NT) to nowe podej\u015bcie do leczenia niep\u0142odno\u015bci, kt\u00f3re polega na przeniesieniu materia\u0142u j\u0105drowego pacjentki do cytoplazmy kom\u00f3rki jajowej dawczyni.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/\" \/>\n<meta property=\"og:site_name\" content=\"IVMED Family Agency\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ivmed.agency\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-16T12:35:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-16T12:45:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1068\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Oksana Yemets\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisane przez\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oksana Yemets\" \/>\n\t<meta name=\"twitter:label2\" content=\"Szacowany czas czytania\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/\"},\"author\":{\"name\":\"Oksana Yemets\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#\\\/schema\\\/person\\\/067b6631b18ef3fe481886cf7e1f67a2\"},\"headline\":\"Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci\",\"datePublished\":\"2024-07-16T12:35:48+00:00\",\"dateModified\":\"2024-07-16T12:45:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/\"},\"wordCount\":577,\"publisher\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/ivf-with-donor-sperm-lab-procedure.jpg\",\"articleSection\":[\"Blog o niep\u0142odno\u015bci\"],\"inLanguage\":\"pl-PL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/\",\"url\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/\",\"name\":\"Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci - IVMED Family Agency\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/ivf-with-donor-sperm-lab-procedure.jpg\",\"datePublished\":\"2024-07-16T12:35:48+00:00\",\"dateModified\":\"2024-07-16T12:45:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/#breadcrumb\"},\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/ivf-with-donor-sperm-lab-procedure.jpg\",\"contentUrl\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/ivf-with-donor-sperm-lab-procedure.jpg\",\"width\":1600,\"height\":1068},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ivmed.agency\\\/pl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infertility Blog\",\"item\":\"https:\\\/\\\/ivmed.agency\\\/category\\\/infertility-blog\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#website\",\"url\":\"https:\\\/\\\/ivmed.agency\\\/\",\"name\":\"In-Vitro Fertility Medicine and Surrogacy Programs. IVMED Clinic, Ukraine\",\"description\":\"High-quality IVF services and surrogacy\",\"publisher\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ivmed.agency\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#organization\",\"name\":\"IVMED Family Agency - IVF and Surrogacy Programs\",\"url\":\"https:\\\/\\\/ivmed.agency\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/ivmed-family-logo-RGB-gorizontal-1.png\",\"contentUrl\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/ivmed-family-logo-RGB-gorizontal-1.png\",\"width\":1000,\"height\":256,\"caption\":\"IVMED Family Agency - IVF and Surrogacy Programs\"},\"image\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ivmed.agency\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#\\\/schema\\\/person\\\/067b6631b18ef3fe481886cf7e1f67a2\",\"name\":\"Oksana Yemets\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g\",\"caption\":\"Oksana Yemets\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci - IVMED Family Agency","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/","og_locale":"pl_PL","og_type":"article","og_title":"Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci - IVMED Family Agency","og_description":"Transfer j\u0105drowy (NT) to nowe podej\u015bcie do leczenia niep\u0142odno\u015bci, kt\u00f3re polega na przeniesieniu materia\u0142u j\u0105drowego pacjentki do cytoplazmy kom\u00f3rki jajowej dawczyni.","og_url":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/","og_site_name":"IVMED Family Agency","article_publisher":"https:\/\/www.facebook.com\/ivmed.agency","article_published_time":"2024-07-16T12:35:48+00:00","article_modified_time":"2024-07-16T12:45:20+00:00","og_image":[{"width":1600,"height":1068,"url":"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg","type":"image\/jpeg"}],"author":"Oksana Yemets","twitter_card":"summary_large_image","twitter_misc":{"Napisane przez":"Oksana Yemets","Szacowany czas czytania":"3 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/#article","isPartOf":{"@id":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/"},"author":{"name":"Oksana Yemets","@id":"https:\/\/ivmed.agency\/#\/schema\/person\/067b6631b18ef3fe481886cf7e1f67a2"},"headline":"Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci","datePublished":"2024-07-16T12:35:48+00:00","dateModified":"2024-07-16T12:45:20+00:00","mainEntityOfPage":{"@id":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/"},"wordCount":577,"publisher":{"@id":"https:\/\/ivmed.agency\/#organization"},"image":{"@id":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/#primaryimage"},"thumbnailUrl":"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg","articleSection":["Blog o niep\u0142odno\u015bci"],"inLanguage":"pl-PL"},{"@type":"WebPage","@id":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/","url":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/","name":"Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci - IVMED Family Agency","isPartOf":{"@id":"https:\/\/ivmed.agency\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/#primaryimage"},"image":{"@id":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/#primaryimage"},"thumbnailUrl":"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg","datePublished":"2024-07-16T12:35:48+00:00","dateModified":"2024-07-16T12:45:20+00:00","breadcrumb":{"@id":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/#breadcrumb"},"inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/"]}]},{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/#primaryimage","url":"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg","contentUrl":"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg","width":1600,"height":1068},{"@type":"BreadcrumbList","@id":"https:\/\/ivmed.agency\/pl\/transfer-jadrowy-nowe-podejscie-do-leczenia-nieplodnosci\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ivmed.agency\/pl\/"},{"@type":"ListItem","position":2,"name":"Infertility Blog","item":"https:\/\/ivmed.agency\/category\/infertility-blog\/"},{"@type":"ListItem","position":3,"name":"Transfer j\u0105drowy: nowe podej\u015bcie do leczenia niep\u0142odno\u015bci"}]},{"@type":"WebSite","@id":"https:\/\/ivmed.agency\/#website","url":"https:\/\/ivmed.agency\/","name":"In-Vitro Fertility Medicine and Surrogacy Programs. IVMED Clinic, Ukraine","description":"High-quality IVF services and surrogacy","publisher":{"@id":"https:\/\/ivmed.agency\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ivmed.agency\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"},{"@type":"Organization","@id":"https:\/\/ivmed.agency\/#organization","name":"IVMED Family Agency - IVF and Surrogacy Programs","url":"https:\/\/ivmed.agency\/","logo":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/ivmed.agency\/#\/schema\/logo\/image\/","url":"https:\/\/ivmed.agency\/wp-content\/uploads\/2023\/03\/ivmed-family-logo-RGB-gorizontal-1.png","contentUrl":"https:\/\/ivmed.agency\/wp-content\/uploads\/2023\/03\/ivmed-family-logo-RGB-gorizontal-1.png","width":1000,"height":256,"caption":"IVMED Family Agency - IVF and Surrogacy Programs"},"image":{"@id":"https:\/\/ivmed.agency\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ivmed.agency"]},{"@type":"Person","@id":"https:\/\/ivmed.agency\/#\/schema\/person\/067b6631b18ef3fe481886cf7e1f67a2","name":"Oksana Yemets","image":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/secure.gravatar.com\/avatar\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g","caption":"Oksana Yemets"}}]}},"_links":{"self":[{"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/posts\/11227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/comments?post=11227"}],"version-history":[{"count":1,"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/posts\/11227\/revisions"}],"predecessor-version":[{"id":11228,"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/posts\/11227\/revisions\/11228"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/media\/11210"}],"wp:attachment":[{"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/media?parent=11227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/categories?post=11227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ivmed.agency\/pl\/wp-json\/wp\/v2\/tags?post=11227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}